HTG Molecular Diagnostics, Inc
HTGMDelisted Jul 10, 2023- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001169987
HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in HTG Molecular Diagnostics, Inc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +2 vs. Q1 2021
- Shares held
- 3.40M
- +1.28M (+60.1%) vs. Q1 2021
- Total value
- $19.7M
- +$8.58M (+76.8%) vs. Q1 2021
- New holders
- 5
- 10 more added
- Sold out
- 3
- 4 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HTGM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 12 | $67.3K |
| Q4 2022 | 10 | $66.2K |
| Q3 2022 | 19 | $283.0K |
| Q2 2022 | 22 | $622.0K |
| Q1 2022 | 22 | $3.19M |
| Q4 2021 | 23 | $14.5M |
| Q3 2021 | 23 | $16.4M |
| Q2 2021 | 25 | $19.7M |
| Q1 2021 | 23 | $11.2M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding HTG Molecular Diagnostics, Inc; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 37 | $0 | 0.00% | +9+32.1% | Added |
| TCI Wealth Advisors, Inc. | 26 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 59 | $0 | 0.00% | +33+126.9% | Added |
| Advisor Group Holdings, Inc. | 24 | $0 | 0.00% | 00.0% | Unchanged |
| Ironwood Financial, llc | 103 | $1.00K | 0.00% | 00.0% | Unchanged |
| Sonora Investment Management, LLC | 466 | $3.00K | 0.00% | +466 | New |
| Allworth Financial LP | 3,327 | $19.0K | 0.00% | 00.0% | Unchanged |
| Advisory Services Network, LLC | 3,700 | $21.0K | 0.00% | +3,700 | New |
| HighMark Wealth Management LLC | 6,966 | $40.0K | 0.03% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 9,129 | $53.0K | 0.00% | +9,095+26,750.0% | Added |
| Squarepoint Ops LLC | 12,181 | $71.0K | 0.00% | −13,973−53.4% | Reduced |
| State Street Corp | 14,043 | $82.0K | 0.00% | +14,043 | New |
| PDT Partners, LLC | 15,501 | $90.0K | 0.01% | +15,501 | New |
| BlackRock Inc. | 15,529 | $91.0K | 0.00% | −3,731−19.4% | Reduced |
| Morgan Stanley | 31,668 | $184.0K | 0.00% | +30,279+2,179.9% | Added |
| Geode Capital Management, LLC | 47,138 | $273.0K | 0.00% | +12,111+34.6% | Added |
| Renaissance Technologies LLC | 57,116 | $332.0K | 0.00% | −81,669−58.8% | Reduced |
| Worth Venture Partners, LLC | 143,135 | $832.0K | 0.31% | +88,388+161.4% | Added |
| Blue Water Life Science Advisors, LLC | 144,881 | $841.0K | 0.32% | −4,114−2.8% | Reduced |
| Vanguard Group Inc | 243,325 | $1.41M | 0.00% | +135,298+125.2% | Added |
| Nantahala Capital Management, LLC | 363,622 | $2.11M | 0.12% | 00.0% | Unchanged |
| Samjo Capital LLC | 534,000 | $3.10M | 2.10% | +104,000+24.2% | Added |
| Cowen Prime Services LLC | 570,333 | $3.31M | 1.20% | +46,300+8.8% | Added |
| Cowen Prime Advisors LLC | 570,333 | $3.31M | 1.20% | +570,333 | New |
| AIGH Capital Management LLC | 612,000 | $3.56M | 0.96% | +380,000+163.8% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,812−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −10,871−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −19−100.0% | Sold out |